Randomized, Double-blind, Placebo, Controlled Cross Over Design Topical Morphine for Analgesia in Pediatric Procedures

Sponsor
Hospital General de Niños Pedro de Elizalde (Other)
Overall Status
Withdrawn
CT.gov ID
NCT02300194
Collaborator
(none)
0
1
2
64
0

Study Details

Study Description

Brief Summary

Introduction:

Opioids, such as morphine, act at receptors in the central nervous system, but many studies have suggested direct action peripherally on opioid receptors in sensory neurons terminals, melanocytes, keratinocytes and fibroblasts. These receptors are stimulated when occurs inflammatory processes.

Hypothesis:

Treatment with topical morphine 0.1% applied 30 minutes before an invasive procedure, decreases pain in children.

Method:

A randomised double-blind parallel study to evaluate the effect of topical application of a 0.1% morphine gel in patients undergo a procedure. 22 patients in each group will be included. Randomly assigned to either the morphine gel or a placebo hydrogel, it will be applied 30 minutes before the procedure and the first day every 4 hours. General basic sedation and systemic analgesia will give for all the patients. Efficacy of treatment will be measured with "Face, Legs, Activity, Cry, Consolability scale" (FLACC scale).

Condition or Disease Intervention/Treatment Phase
  • Drug: Topic Morphine
  • Drug: Placebo
Phase 4

Detailed Description

The use of an opioid such as morphine topical gel 30 minutes before a procedure would be effective in reducing pain in children. It has proven effective analgesic with minimal adverse effects, especially in children older than 6 months, and even its use is authorized in young children.

Study Design

Study Type:
Interventional
Actual Enrollment :
0 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Triple (Participant, Care Provider, Investigator)
Primary Purpose:
Treatment
Official Title:
Topical Morphine for Analgesia in Pediatric Procedures. Clinical Trial Randomized, Double-blind, Placebo.
Study Start Date :
Dec 1, 2014
Actual Primary Completion Date :
Apr 1, 2020
Anticipated Study Completion Date :
Apr 1, 2020

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Topic Morphine

Use of topic morphine for treatment of procedure associated pain

Drug: Topic Morphine
Topical application of a 0.1% morphine gel in patients undergo a procedure. It will be applied 30 minutes before the procedure and the first day every 4 hours. General basic sedation and systemic analgesia will give for all the patients. Efficacy of treatment will be measured with FLACC scale.
Other Names:
  • Morphine gel
  • Placebo Comparator: Placebo

    Use of topic hydrogel (placebo) for treatment of procedure associated pain

    Drug: Placebo
    Topical application of a placebo hydrogel in patients undergo a procedure. It will be applied 30 minutes before the procedure and the first day every 4 hours. General basic sedation and systemic analgesia will give for all the patients. Efficacy of treatment will be measured with FLACC scale.
    Other Names:
  • Placebo hidrogel
  • Outcome Measures

    Primary Outcome Measures

    1. Pain Reduction [4 hours]

      Proportion of patients with a reduction in pain of least 2 point according to FLACC scale

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    1 Month to 10 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Hospitalized children aged 1 month to 10 years, who needs a medical procedure over previously injured skin, associated with moderate-severe pain.
    Exclusion Criteria:
    • Refusal to participate

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Hospital General de Niños Pedro de Elizalde Ciudad Autonoma de Buenos Aires Argentina C1270AAN

    Sponsors and Collaborators

    • Hospital General de Niños Pedro de Elizalde

    Investigators

    • Principal Investigator: María L Yazde-Puleio, MD, Hospital General de Niños Pedro de Elizalde

    Study Documents (Full-Text)

    None provided.

    More Information

    Additional Information:

    Publications

    Responsible Party:
    Hospital General de Niños Pedro de Elizalde
    ClinicalTrials.gov Identifier:
    NCT02300194
    Other Study ID Numbers:
    • HGNPE-157
    First Posted:
    Nov 24, 2014
    Last Update Posted:
    Apr 22, 2020
    Last Verified:
    Apr 1, 2020
    Keywords provided by Hospital General de Niños Pedro de Elizalde
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Apr 22, 2020